THOMPSON JOHN CRAIG 4
4 · Anthera Pharmaceuticals Inc · Filed Sep 20, 2017
Insider Transaction Report
Form 4
THOMPSON JOHN CRAIG
DirectorPresident & CEO
Transactions
- Purchase
Common stock
2017-09-20$1.32/sh+8,550$11,286→ 19,848 total
Footnotes (1)
- [F1]The Reporting Person acquired the shares in the open market at a cost of $1.32 per share.